Search

everythinglearnresearchcommunity

for

Search:↓

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

Vitiligo transplantation surgery is now more efficient, cost-effective, and successful.

Melanoma cells lose their ability to form tumors when placed in a zebrafish embryo environment.

Melanocyte transplantation can safely restore skin color, especially in stable vitiligo, but must be chosen carefully based on the disease phase.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Cardiac xenotransplantation is moving towards clinical use with growing research and collaboration.

Injecting patients' own PRP into their thyroid improved thyroid function and symptoms in most hypothyroidism cases.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

A 17-year-old boy with Temporal Triangular Alopecia successfully grew new hair after a hair restoration surgery using follicular unit transplantation.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

The treatment improved hair color in most vitiligo patients without major side effects.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Thymosin β4 helps improve skin healing and reduce scarring.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Switching immunosuppressive drugs can improve hair regrowth and well-being in transplant patients with hair loss.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Transplanted bone marrow cells actively move, form clusters, and grow after transplantation.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

A rare skin infection in a 10-year-old kidney transplant patient was successfully managed by adjusting medication.

A kidney transplant and immunosuppressive treatment stopped the skin disease in a patient.